S

Sandile Cele

Africa Health Research Institute

ORCID: 0000-0002-0905-7164

Publishes on SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, HIV Research and Treatment. 42 papers and 4.6k citations.

PubIndex Score98Top 2% · mid-careerHow it's scored

🔥#1 Rising Star in PARP inhibition in cancer therapy 🔥#3 Rising Star in CRISPR and Genetic Engineering

42Publications

4.6kTotal Citations

#1in PARP inhibition in cancer therapy

First publication: 2018First senior author: 2022

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies HIV Research and Treatment SARS-CoV-2 detection and testing HIV/AIDS Research and Interventions

Top publicationsby citations

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sandile Cele, Nokuthula Ngcobo, Nombulelo Magula et al.|Nature|2021

Cited by 1.2k

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

Alex Sigal, Sandile Cele, Inbal Gazy et al.|Nature|2021

Cited by 713

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Roanne Keeton, Catherine Riou, Marius B. Tincho et al.|Nature|2022

Cited by 623

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

Sandile Cele, Alex Sigal, Laurelle Jackson et al.|medRxiv|2021

Cited by 366

SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape

Sandile Cele, Alex Sigal, Farina Karim et al.|Cell Host & Microbe|2022

Cited by 241